Viking Therapeutics (VKTX)
NASDAQ:VKTX
Holding VKTX?
Track your performance easily

Viking Therapeutics (VKTX) Financial Statements

4,781 Followers

Viking Therapeutics Financial Overview

Viking Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.936; its P/E ratio is -77.81; Viking Therapeutics is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -24.94M$ -22.25M$ -27.36M$ 4.48M$ -22.53M
EBITDA$ -24.83M$ -19.34M$ -30.07M$ 33.57M-
Net Income Common Stockholders$ -24.94M$ -22.23M$ -27.36M$ -24.61M$ -22.53M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 930.44M$ 942.26M$ 962.98M$ 362.08M$ 376.24M
Total Assets$ 937.89M$ 946.84M$ 967.52M$ 368.49M$ 382.66M
Total Debt$ 1.24M$ 1.10M$ 1.18M$ 1.26M$ 1.34M
Net Debt$ -929.21M$ -941.16M$ -961.79M$ -360.82M$ -374.90M
Total Liabilities$ 26.44M$ 25.86M$ 33.63M$ 20.07M$ 14.42M
Stockholders Equity$ 911.45M$ 920.98M$ 933.89M$ 348.42M$ 368.24M
Cash Flow-
Free Cash Flow$ -21.96M$ -28.51M$ -6.13M$ -17.64M-
Operating Cash Flow$ -21.96M$ -28.51M$ -6.13M$ -17.64M$ -19.66M
Investing Cash Flow$ 25.90M$ -126.06M$ -459.79M$ 35.73M$ -12.53M
Financing Cash Flow$ 2.52M$ 2.90M$ 606.04M$ 188.00K$ -74.00K
Currency in USD

Viking Therapeutics Earnings and Revenue History

Viking Therapeutics Debt to Assets

Viking Therapeutics Cash Flow

Viking Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis